US Patent 10450288 Hydroxy formamide derivatives and their use
Patent 10450288 was granted and assigned to GlaxoSmithKline on October, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+58 characters)
Article
Patent abstract
Disclosed are compounds having the formula:
Edits on 3 Oct, 2023
Golden AI
Edits made to:
Infobox (+13 properties)
Infobox
Patent Inventor Names
Brian Griffin Lawhorn0
David G. Washburn0
Guosen Ye0
Hilary Schenck Eidam0
Joanne Philp0
Lara Kallander0
Mark A. Hilfiker0
Mark Elban0
Marlys Hammond0
Ryan Michael Fox0
Sarah E. Dowdell0
Sharada Manns0
Tram H. Hoang0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
104502880
Date of Patent
October 22, 2019
0Patent Application Number
151107760
Date Filed
January 9, 2015
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 29 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10450288 Hydroxy formamide derivatives and their use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10450288
Date of patent
October 22, 2019
Patent application number
15110776
Date Filed
January 9, 2015
Patent primary examiner
Find more entities like US Patent 10450288 Hydroxy formamide derivatives and their use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.